Allergan plc 3 SEC Filings

Filed On	Filing
20 Feb 2019	Form 3: Hugin Robert J, Director Holds 3,000 shares of Ordinary Shares, par value $0.0001
08 Aug 2018	Form 3: Greenberg Michael Eldon, Director No securities owned
15 Jun 2018	Form 3: Freyman Thomas C, Director No securities owned
03 May 2018	Form 3: Davidson Carol Anthony, Director No securities owned
21 Feb 2018	Form 3: Walsh Matthew M, EVP, Chief Financial Officer No securities owned
19 Jan 2018	Form 3: Swanton Wayne R, EVP, Global Operations Holds 742 shares of Ordinary Shares, par value $0.0001
20 Jul 2017	Form 3: Boccuzi Joseph H, Director No securities owned
16 May 2017	Form 3: Princen Marc, EVP and President Int'l Comml Holds 8,298 shares of Ordinary Shares, par value $0.0001
06 Feb 2017	Form 3: Brown Adriane M, Director No securities owned
29 Sep 2016	Form 3: Allergan plc, 10% owner and 2 others · Tobira Therapeutics, Inc. Holds 0 shares of Common Stock, par value $0.001
16 May 2016	Form 3: Nicholson C. David, Chief R&D Officer Holds 8,103 shares of Ordinary Shares, par value $0.0001
19 Mar 2015	Form 3: Gallagher Michael R, Director No securities owned
19 Mar 2015	Form 3: Navarre Paul, See Remarks No securities owned
19 Mar 2015	Form 3: McDonnell Peter J, Director No securities owned
19 Mar 2015	Form 3: Schaison Philippe, See Remarks No securities owned
10 Dec 2014	Form 3: Hilado Maria Teresa, Chief Financial Officer No securities owned
03 Jul 2014	Form 3: Basgoz Nesli, Director No securities owned
03 Jul 2014	Form 3: Coughlin Christopher J, Director No securities owned
03 Jul 2014	Form 3: Ling Karen, Chief Human Resources Officer No securities owned
03 Jul 2014	Form 3: Meury William, EVP, N.A. Commercial No securities owned

Comments